Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Chimeric antigen receptor (CAR)
Sort By
Newest First
1 / 1
1 / 1
Phase I Trial
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center
Anixa Biosciences
PR-M03-22-17
Mar 30, 2022
Innovation
Research Collaboration Will Focus on the Development of New CAR T-Cell Treatments
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M07-17-NI-007
Jul 07, 2017
Biologics
Pharma Revs Up Cancer-Fighting CAR T-Cell Therapy
Emilie Branch
Pharma's Almanac
MCP-M06-17-NI-001
Jun 08, 2017
